share_log

拓新药业(301089.SZ):产品四乙酰核糖、烟酰胺核苷(NR)可作为中间体,用于下游NMN的生产

Tuoxin Pharmaceutical (301089.SZ): products such as Tetraacetylribose and Nicotinamide Riboside (NR) can be used as intermediates for the production of downstream NMN.

Gelonghui Finance ·  Aug 14 05:56

On August 14th, Bio-Thera Solutions (301089.SZ) stated on the investor platform that its product, tetraacetyl ribose and nicotinamide riboside (NR), can serve as intermediates for downstream production of NMN.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment